This article first appeared on GuruFocus .
Release Date: August 21, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Enero Group Ltd ( ASX:EGG ) delivered strong financial results with 9% EBITDA growth and a 54% increase in net profit and EPS, despite a slight revenue decline.
-
The company achieved significant margin expansion, with group EBITDA margin growing from 10.2% to 11.8%, driven by disciplined cost management and operational excellence.
-
Australian agencies, particularly BMF and Orchard, delivered record performances with top-tier EBITDA margins of 23% and 21.8%, respectively, in a tough competitive market.
-
The implementation of AI across the group has yielded tangible efficiency gains, such as a 93% reduction in time processing complex briefs at BMF and a 50% faster brief-to-insight time at Hotwire.
-
The company maintains a strong balance sheet with net cash of $24.5 million, zero leverage, and a diversified revenue mix with 60% from retainers, providing stability.
Negative Points
-
Hotwire continues to face significant challenges, with a 19% decline in revenue and a 33% drop in EBITDA due to a difficult US market and AI disruption in the core technology sector.
-
The ROI-DNA business is expected to see a 30-50% revenue reduction in FY27 as clients bring work in-house, necessitating further restructuring and cost cuts.
-
The company recorded a statutory net loss of $37.4 million, largely due to a $39.8 million non-cash impairment and intangible write-down related to ROI-DNA's near-term performance.
-
Revenue planning for FY27 indicates a potential 5-15% decline on a run-rate basis for Hotwire, reflecting ongoing AI disruption and technology industry volatility.
-
Cash conversion was weak at 62% of EBITDA, impacted by restructuring costs and a $3 million negative working capital movement, leading to free cash flow of only $1.1 million.
Q & A Highlights
-
Warning! GuruFocus has detected 4 Warning Signs with ASX:EGG.
-
Is ASX:EGG fairly valued? Test your thesis with our free DCF calculator.
Q: What is the outlook for Hotwire and its ROI-DNA unit, and what actions are being taken to address the anticipated revenue decline? A: Ian Ball (COO) stated that Hotwire remains a business in transition, with the impact of AI on core technology clients being a major factor. The company expects a revenue reduction of 30% to 50% for the ROI-DNA unit in FY27. To mitigate this, they are taking affirmative action to restructure ROI, integrating its capabilities more closely into Hotwire to create a materially lower cost base and a simpler operating model. Overall, Hotwire's FY27 revenue planning is between 5% and 15% below the FY26 second-half run rate, reflecting AI disruption and continued volatility in the technology industry.
Q: Can you elaborate on the financial performance of the Australian agencies, BMF and Orchard, in FY26? A: Ian Ball (COO) highlighted that both agencies delivered exceptionally strong results in a tough market. BMF achieved record EBITDA of $8.8 million and a 23% EBITDA margin, up from 20.1% last year, driven by an 11% revenue growth and a significant transformation of its operating model. Orchard had a record year with revenue of $28 million, record EBITDA of $6.1 million, and a 21.8% EBITDA margin, up from 19%. This was fueled by strong performance in its healthcare vertical, including being selected as the agency of record for Lilly's GLP-1 portfolio in Australia and New Zealand.
Q: What were the key drivers behind the group's EBITDA margin expansion from 10.2% to 11.8%? A: Ian Ball (COO) attributed the margin growth to a disciplined focus on execution and cost management across both the corporate center and the agencies. This was significantly enabled by the implementation of AI, which improved efficiency and effectiveness. The company focused on AI initiatives that passed a test of delivering either an efficiency gain or an effectiveness gain, leading to a reduction in the staff cost ratio from 78% to 75% at the group level.
Q: What is the strategic importance of the AI Lab, and what tangible results has it delivered? A: Ian Ball (COO) explained that the AI Lab serves a dual purpose. First, it creates market-facing products that generate significant commercial benefit, with revenue growing 3 times higher in Q4 compared to Q1. When embedded into pitches, these AI capabilities increase win rates by 30%. Second, it empowers the entire group's AI transformation. For example, in Hotwire, AI-enabled research has increased the brief-to-insight time by 50%, and overall, the company is generating a 45% reduction in time spent on analytical drafting for quarterly client reports.
Q: How is BMF leveraging AI to improve its operational efficiency and creative output? A: Ian Ball (COO) detailed BMF's major transformation, which included deploying two key AI agents for a large client. These agents have reduced image production delivery time by 36% and processing time for complex briefs by 93%, turning days of work into hours. The company also launched "Noggin," an internal AI agent with 30 skills available to all staff, which captures institutional knowledge to enhance creative briefs and pitches. Overall, this has resulted in 31% faster end-to-end retail production.
Q: What is the outlook for BMF in FY27, and how is the company preparing for it? A: Ian Ball (COO) stated that BMF's FY27 revenue planning assumes a 10% to 15% decline from the FY26 second half, reflecting changes in its client portfolio, including the loss of Westpac and Endeavour. However, the company has transformed its operating model to drive a lower cost base and expects margins to continue improving. BMF has a strong pipeline and recently won major new clients like Asahi and Superloop. They are also developing a full-service capability in Melbourne to serve Asahi and pursue new business.
Q: What were the main components of the significant items that led to a statutory net loss of $37.4 million? A: Tracy Leung (CFO) explained that the significant items totaled $41.8 million, which were largely noncash in nature. The primary driver was a $39.8 million impairment loss and intangible write-down, mainly related to the near-term performance of ROI-DNA. Other items included noncash reassessment of useful life and fair value adjustments, as well as $3.8 million in restructuring and other costs related to transformation efforts in Hotwire and BMF.
Q: Can you provide details on the company's cash flow and balance sheet position? A: Tracy Leung (CFO) reported that cash conversion was 62% of EBITDA, impacted by restructuring costs and a $3 million negative working capital movement related to client-held cash. Free cash flow was $1.1 million. The company ended the year with a net cash position of $24.5 million and zero leverage, with $11.4 million of its $15 million bank facility undrawn. The facility was extended until October 2026.
Q: What is the outlook for Orchard in FY27? A: Ian Ball (COO) indicated that Orchard has very positive momentum and expects this to continue strongly in FY27. The company plans to build out geographic expansion in both healthcare and consumer sectors to deliver additional revenue. Orchard will also continue to roll out its "Agentic by default" AI-led delivery model to drive further efficiency gains.
Q: What is the company's dividend policy and what was the payout for FY26? A: Ian Ball (COO) announced a fully franked dividend of $0.014 per share, representing a payout ratio of 31% of adjusted EPS. This is consistent with the company's historical payout ratio of 30% to 50% of adjusted earnings per share.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
